Ventricular Assist Device Market [2022-2028] | to Reach USD 2.24 Billion, with healthy 8.9% CAGR

Key Companies Covered in Ventricular Assist Device Market are - Abbott Laboratories (U.S.), Berlin Heart GmbH (Germany), Medtronic (Ireland), Cardiac Assist, Inc. (U.S.), Jarvik Heart, Inc. (U.S.), ReliantHeart (U.S.), ABIOMED (U.S.), Sun Medical Technology Research Corp (Japan)


Pune, India, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The global ventricular assist device market size was USD 1.12 billion in 2020. The market is projected to grow from USD 1.23 billion in 2021 to USD 2.24 billion in 2028 at a CAGR of 8.9% during the 2021-2028 period. This information is provided by Fortune Business Insights™, in its report, titled, “Ventricular Assist Device Market, 2021-2028.”

Industry Development

February 2021: CARMAT has gained sanction for the usage of novel version of its artificial heart in the Early Feasibility Study (EFS). This novel variety comprises specific enhancements in the prosthesis and the wearable system grounded on clinical experience attained in the PIVOTAL study.


Request Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ventricular-assist-device-market-106377


Ventricular Assist Device Market Report Scope:

Report CoverageDetails
Forecast Period2021 to 2028
Forecast Period 2021 to 2028 CAGR8.9%
2028 Value ProjectionUSD 2.24 billion
Base Year2020
Market Size in 2021 USD 1.23 billion
Historical Data for2017 to 2019
No. of Pages150
Segments coveredBy Type, By Procedure, By Geography
Growth DriversBased on our analysis, the global market exhibited a stellar growth of -9.19% in 2020 compared to the average year-on-year growth during 2017-2019.
The sudden rise in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.
The factors such as the increasing prevalence of heart failure, awareness regarding treatment for heart failure and rising applications of these devices in heart failure are contributing to the growth of the market during the forecast period of 2021-2028.


To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/ventricular-assist-device-market-106377


Ventricular Assist Device Market Growth Factors:

  • Heart failure is among the dominating reasons of mortality globally, impacting over 1-2% of the population in western nations. As per the American Heart Association (AHA), the occurrence of heart failure is estimated to augment at a substantial development pace by 2030, in the U.S. is expected to reach over 8 million patients.
  • Furthermore, in 2020, across the world, over 5.5 million people are predicted to be impacted by heart failure. Mentioning the surging number of patients experiencing the condition, numerous producers are undertaking initiatives for the obtainability of ventricular assist devices.


Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/ventricular-assist-device-market-106377


Regional Insights

  • The Ventricular Assist Device Market size in North America stood at USD 0.45 billion in 2020. The leading nature of this regional market is accredited to the growing implementation of advanced diagnostics for the identification of heart failure and the increasing incidence of cardiovascular diseases in this region.
  • Europe held the second-largest ventricular assist device market share and is anticipated to rise at a substantial CAGR owing to the growing investments in the market pooled with fresher product promotions.
  • The market in the Asia Pacific displayed a higher CAGR owing to the progressions in the healthcare amenities and encouraging government strategies.


Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/ventricular-assist-device-market-106377


List of Key Players Covered in the Report

  • Abbott Laboratories (U.S.)
  • Berlin Heart GmbH (Germany)
  • Medtronic (Ireland)
  • Cardiac Assist, Inc. (U.S.)
  • Jarvik Heart, Inc. (U.S.)
  • ReliantHeart (U.S.)
  • ABIOMED (U.S.)
  • Sun Medical Technology Research Corp (Japan)


Ventricular Assist Device Market Table Of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Number of Cardiac Surgeries, By Region/Country, 2020
    • New Product Launches, By Key Players
    • Impact of COVID-19 on the Market
    • Recent Key Developments, Mergers, and Acquisitions, Key Players
  • Global Ventricular Assist Device Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Left Ventricular Assist Device
      • Right Ventricular Assist Device
      • Bi-Ventricular Assist Device
    • Market Analysis, Insights and Forecast – By Type
      • Pulsatile Flow
      • Continuous Flow
    • Market Analysis, Insights and Forecast – By Application
      • Bridge to Transplant (BTT)
      • Bridge to Candidacy (BTC)
      • Destination Therapy (DT)
      • Bridge to Recovery (BTR)
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals & ASCs
      • Specialty Clinics & Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Ventricular Assist Device Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Left Ventricular Assist Device
      • Right Ventricular Assist Device
      • Bi-Ventricular Assist Device
    • Market Analysis, Insights and Forecast – By Type
      • Pulsatile Flow
      • Continuous Flow
    • Market Analysis, Insights and Forecast – By Application
      • Bridge to Transplant (BTT)
      • Bridge to Candidacy (BTC)
      • Destination Therapy (DT)
      • Bridge to Recovery (BTR)
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals & ASCs
      • Specialty Clinics & Others
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
        • By Product
      • Canada
        • By Product


Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/ventricular-assist-device-market-106377


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com